156 related articles for article (PubMed ID: 21697062)
21. [TNF-alpha inhibitors].
Fain O
Rev Prat; 2003 Nov; 53(18):1989-90. PubMed ID: 15008210
[No Abstract] [Full Text] [Related]
22. Effects of etanercept on C-reactive protein levels in psoriasis and psoriatic arthritis.
Strober B; Teller C; Yamauchi P; Miller JL; Hooper M; Yang YC; Dann F
Br J Dermatol; 2008 Aug; 159(2):322-30. PubMed ID: 18503600
[TBL] [Abstract][Full Text] [Related]
23. Differential effect of etanercept on cutaneous and joint lesions in psoriatic arthritis.
Mizote Y; Nakahara T; Mitoma C; Nakao M; Mitoma H; Moroi Y; Furue M
J Dermatol; 2012 Mar; 39(3):284-5. PubMed ID: 21950550
[No Abstract] [Full Text] [Related]
24. Efficacy, effectiveness and safety of etanercept in monotherapy for refractory psoriatic arthritis: a 26-week observational study.
de Vlam K; Lories RJ
Rheumatology (Oxford); 2006 Mar; 45(3):321-4. PubMed ID: 16234275
[TBL] [Abstract][Full Text] [Related]
25. Psoriatic arthritis in a military aviator.
Sulit DJ; Clarke JE
Aviat Space Environ Med; 2005 Jul; 76(7):684-8. PubMed ID: 16018354
[TBL] [Abstract][Full Text] [Related]
26. Effect of etanercept on insulin secretion and insulin sensitivity in a randomized trial with psoriatic patients at risk for developing type 2 diabetes mellitus.
Martínez-Abundis E; Reynoso-von Drateln C; Hernández-Salazar E; González-Ortiz M
Arch Dermatol Res; 2007 Nov; 299(9):461-5. PubMed ID: 17726611
[TBL] [Abstract][Full Text] [Related]
27. The treatment of psoriasis and psoriatic arthritis with etanercept: practical considerations on monotherapy, combination therapy, and safety.
Yamauchi PS; Gindi V; Lowe NJ
Dermatol Clin; 2004 Oct; 22(4):449-59, ix. PubMed ID: 15450340
[TBL] [Abstract][Full Text] [Related]
28. Safety and efficacy study on etanercept in patients with plaque psoriasis.
Costanzo A; Mazzotta A; Papoutsaki M; Nisticò S; Chimenti S
Br J Dermatol; 2005 Jan; 152(1):187-9. PubMed ID: 15656833
[No Abstract] [Full Text] [Related]
29. Etanercept: an evolving role in psoriasis and psoriatic arthritis.
Prodanovich S; Ricotti C; Glick BP; Inverardi L; Leonardi CL; Kerdel F
Am J Clin Dermatol; 2010; 11 Suppl 1():3-9. PubMed ID: 20586498
[TBL] [Abstract][Full Text] [Related]
30. Combined treatment with etanercept 50 mg once weekly and narrow-band ultraviolet B phototherapy in chronic plaque psoriasis.
De Simone C; D'Agostino M; Capizzi R; Capponi A; Venier A; Caldarola G
Eur J Dermatol; 2011; 21(4):568-72. PubMed ID: 21697032
[TBL] [Abstract][Full Text] [Related]
31. Efficacy and safety of etanercept in patients with psoriasis and hepatitis C.
Ventura F; Gomes J; Duarte Mda L; Fernandes JC; Brito C
Eur J Dermatol; 2010; 20(6):808-9. PubMed ID: 20923749
[No Abstract] [Full Text] [Related]
32. Long-term etanercept use for severe generalized psoriasis in an HIV-infected individual: a case study.
Lee ES; Heller MM; Kamangar F; Park KK; Koo JY
J Drugs Dermatol; 2012 Mar; 11(3):413-4. PubMed ID: 22395596
[TBL] [Abstract][Full Text] [Related]
33. Safety of etanercept in patients with psoriasis and hepatitis C virus assessed by liver histopathology: preliminary data.
Paradisi A; Caldarola G; Capizzi R; Siciliano M; Annichiarico E; Vecchio FM; Amerio PL; De Simone C
J Am Acad Dermatol; 2010 Jun; 62(6):1067-9. PubMed ID: 20466184
[No Abstract] [Full Text] [Related]
34. Relapsing polychondritis-like ear disease responding to etanercept in two patients with psoriasis and psoriatic arthritis.
Lee HC; Tsai TF
J Am Acad Dermatol; 2011 May; 64(5):1006-7. PubMed ID: 21496717
[No Abstract] [Full Text] [Related]
35. Combination of skin, joint and quality of life outcomes with etanercept in psoriasis and psoriatic arthritis in the PRESTA trial.
Prinz JC; Fitzgerald O; Boggs RI; Foehl J; Robertson D; Pedersen R; Molta CT; Freundlich B
J Eur Acad Dermatol Venereol; 2011 May; 25(5):559-64. PubMed ID: 20840349
[TBL] [Abstract][Full Text] [Related]
36. Effect of calcipotriol on etanercept partial responder psoriasis vulgaris and psoriatic arthritis patients.
Campione E; Mazzotta A; Paternò EJ; Diluvio L; Prinz JC; Chimenti S
Acta Derm Venereol; 2009; 89(3):288-91. PubMed ID: 19479128
[TBL] [Abstract][Full Text] [Related]
37. Etanercept for severe psoriasis and psoriatic arthritis: observations on combination therapy.
Iyer S; Yamauchi P; Lowe NJ
Br J Dermatol; 2002 Jan; 146(1):118-21. PubMed ID: 11841377
[TBL] [Abstract][Full Text] [Related]
38. Pulmonary sarcoidosis associated with etanercept therapy.
Farah RE; Shay MD
Pharmacotherapy; 2007 Oct; 27(10):1446-8. PubMed ID: 17896899
[TBL] [Abstract][Full Text] [Related]
39. [Long-term safety and efficacy of etanercept in the treatment of psoriasis].
Zaragoza V; Pérez A; Sánchez JL; Oliver V; Martínez L; Alegre V
Actas Dermosifiliogr; 2010; 101(1):47-53. PubMed ID: 20109392
[TBL] [Abstract][Full Text] [Related]
40. Successful treatment with etanercept of von Zumbusch pustular psoriasis in a patient with human immunodeficiency virus.
Mikhail M; Weinberg JM; Smith BL
Arch Dermatol; 2008 Apr; 144(4):453-6. PubMed ID: 18427038
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
